Teva Pharmaceutical Industries Limited
TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalantā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
44 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$34.15
Price+0.10%
$0.04
1Y
Price
Market Cap
$39.159b
Large
Price/Earnings 3y Avg5y Avg
28.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+11.9%
EBITDA Margin+10.1%
Net Profit Margin+21.4%
Free Cash Flow Margin+11.9%
EBITDA Margin+10.1%
Net Profit Margin+21.4%
Free Cash Flow MarginRevenue
$17.258b
+4.5%
1y CAGR+5.0%
3y CAGR+2.3%
5y CAGREarnings
$1.409b
+186.0%
1y CAGR+23.3%
3y CAGR-154.2%
5y CAGREPS
$1.20
+182.8%
1y CAGR+23.3%
3y CAGR-152.2%
5y CAGRBook Value
$7.914b
$40.747b
Assets$32.833b
Liabilities$17.382b
DebtDebt to Assets
42.7%
5.6x
Debt to EBITDAFree Cash Flow
$1.148b
-44.0%
1y CAGR+26.8%
3y CAGR+105.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company